SGHT

Sight Sciences, Inc. [SGHT] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SGHT Stock Summary

Top 10 Correlated ETFs

SGHT

Top 10 Correlated Stocks

SGHT

In the News

SGHT Financial details

Company Rating
-
Market Cap
287.91M
Income
-55.55M
Revenue
81.06M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
214
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-4.37
Forward P/E
-
PEG
1.19
P/S
3.27
P/B
2.13
P/C
-
P/FCF
-4.84
Quick Ratio
11.26
Current Ratio
12.11
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.14
EPS next Y
-
EPS next Q
-
EPS this Y
-36.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
15.69%
Revenue last 5Y
28.26%
Revenue Q/Q
-6.29%
EPS Q/Q
-18.52%
-
-
-
-
SMA20
-11.5%
SMA50
-29.25%
SMA100
-56.28%
Inst Own
-
Inst Trans
-
ROA
-35%
ROE
-43%
ROC
-0.39%
Gross Margin
85%
Oper. Margin
-76%
Profit Margin
-75%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.04-11.2
52W High
-78.55%
52W Low
+136%
RSI
36.93
Rel Volume
1.3
Avg Volume
203.11K
Volume
264.89K
Perf Week
-16.01%
Perf Month
-20.27%
Perf Quarter
-64.51%
Perf Half Y
-63.18%
-
-
-
-
Beta
2.825
-
-
Volatility
0.1%, 0.19%
Prev Close
-5.22%
Price
2.36
Change
4.89%

Something similar

Top by Market Cap
EMBASSY.NS
VFINX
CMC.DE
BRYN.DE
LLY.SW
Top Correlated ETFs
QXM.TO
FTXR
LIVP.L
XHE
INOC.TO
Top Correlated Stocks
VMD
BX
BOOT
UMBF
DECK
Similar Market Cap
SYBT.DE
XTR.TO
BOAC
AB9.DE
GAV.SW

Company Profile

Healthcare Medical - Devices
  • Volume Average 203.11K
  • Market Capitalization 287.91M
  • Employee 214
  • CEO Mr. Paul Badawi
  • Headquarters Menlo Park,CA,US
  • IPO Date 2021-07-15
  • Website https://www.sightsciences.com

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.